无 KM 图
入排:排除
图源:开放图源暂不可得
JAAD Game Changers: "Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial".
Jane M Grant-Kels
J Am Acad Dermatol S0190-9622(26)02995-6